Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
STF-083010
i
Other names:
STF-083010
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Shanghai Jiao Tong University
Drug class:
ERN1 inhibitor
Related drugs:
‹
ORIN1001 (1)
ORIN1001 (1)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
quizartinib + STF-083010
Sensitive: D – Preclinical
quizartinib + STF-083010
Sensitive
:
D
quizartinib + STF-083010
Sensitive: D – Preclinical
quizartinib + STF-083010
Sensitive
:
D
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
STF-083010
Sensitive: D – Preclinical
STF-083010
Sensitive
:
D
STF-083010
Sensitive: D – Preclinical
STF-083010
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.